Variant report
Variant | esv3471790 |
---|---|
Chromosome Location | chr6:34697974-34702972 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:34683902..34686435-chr6:34695998..34698813,2 | K562 | blood: | |
2 | chr6:34698371..34700265-chr6:34702057..34704593,2 | K562 | blood: | |
3 | chr6:34696691..34699544-chr6:34703628..34706154,2 | K562 | blood: | |
4 | chr6:34694281..34696402-chr6:34696757..34699128,2 | K562 | blood: | |
5 | chr6:34698371..34700265-chr6:34702057..34704593,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146778275 | chr6:34698012-34698013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547063173 | chr6:34698037-34698038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185143533 | chr6:34698041-34698042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536109056 | chr6:34698047-34698048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140717672 | chr6:34698057-34698058 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371800836 | chr6:34698075-34698076 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569318465 | chr6:34698133-34698134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2814954 | chr6:34698146-34698147 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs557548139 | chr6:34698154-34698155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551579380 | chr6:34698257-34698258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571725549 | chr6:34698298-34698299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34377413 | chr6:34698301-34698302 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs533537897 | chr6:34698306-34698307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150471530 | chr6:34698318-34698319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145406716 | chr6:34698329-34698330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544071705 | chr6:34698368-34698369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562456194 | chr6:34698404-34698405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372870835 | chr6:34698513-34698514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577744970 | chr6:34698531-34698532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116270597 | chr6:34698558-34698559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564419552 | chr6:34698564-34698565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528626659 | chr6:34698668-34698669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10947524 | chr6:34698754-34698755 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs10568611 | chr6:34698786-34698787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs36077178 | chr6:34698892-34698893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562035358 | chr6:34698913-34698914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571770009 | chr6:34698920-34698921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567889912 | chr6:34698947-34698948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2814955 | chr6:34698970-34698971 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs569564057 | chr6:34698977-34698978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138031113 | chr6:34698984-34698985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551993939 | chr6:34698991-34698992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566963778 | chr6:34698994-34698995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533592436 | chr6:34699031-34699032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2764210 | chr6:34699049-34699050 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs200852018 | chr6:34699065-34699066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188040736 | chr6:34699072-34699073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2814956 | chr6:34699109-34699110 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs556161909 | chr6:34699148-34699149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577914067 | chr6:34699161-34699162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181213665 | chr6:34699165-34699166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558591780 | chr6:34699185-34699186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138612688 | chr6:34699186-34699187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572168893 | chr6:34699207-34699208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540698044 | chr6:34699217-34699218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557527311 | chr6:34699218-34699219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185303986 | chr6:34699236-34699237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371051876 | chr6:34699269-34699270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141146476 | chr6:34699287-34699288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191384238 | chr6:34699293-34699294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:34696000-34699000 | Weak transcription | K562 | blood |
2 | chr6:34696400-34699400 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr6:34696400-34700600 | Enhancers | HepG2 | liver |
4 | chr6:34697200-34699200 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr6:34697400-34698200 | Enhancers | Fetal Heart | heart |
6 | chr6:34697400-34698200 | Enhancers | HSMM | muscle |
7 | chr6:34697400-34698200 | Enhancers | HSMMtube | muscle |
8 | chr6:34697600-34698200 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr6:34697600-34698200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr6:34697800-34698000 | Enhancers | Esophagus | oesophagus |
11 | chr6:34697800-34698200 | Enhancers | Left Ventricle | heart |
12 | chr6:34697800-34698200 | Enhancers | Psoas Muscle | Psoas |
13 | chr6:34698000-34714000 | Weak transcription | Esophagus | oesophagus |
14 | chr6:34698200-34698400 | Enhancers | Stomach Mucosa | stomach |
15 | chr6:34698400-34699000 | Weak transcription | Stomach Mucosa | stomach |
16 | chr6:34699000-34699400 | Enhancers | K562 | blood |
17 | chr6:34699000-34699800 | Enhancers | Stomach Mucosa | stomach |
18 | chr6:34699200-34700000 | Enhancers | Liver | Liver |
19 | chr6:34699400-34707000 | Weak transcription | K562 | blood |
20 | chr6:34699800-34712200 | Weak transcription | Stomach Mucosa | stomach |
21 | chr6:34700600-34703000 | Weak transcription | HepG2 | liver |